Related Experiment Video
Updated: Jul 11, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Clozapine-induced leukopenia successfully treated with lithium
Eric C Kutscher1, Garry P Robbins, W Klugh Kennedy
1College of Pharmacy, South Dakota State University, Sioux Falls, SD 57110, USA. eric.kutscher@mckennan.org
Summary
Lithium successfully treated clozapine-induced leukopenia in a schizophrenia patient, enabling continued clozapine therapy. This approach managed white blood cell counts, preventing rehospitalization and maintaining psychiatric stability.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Clozapine is an effective antipsychotic for schizophrenia but carries a risk of agranulocytosis and leukopenia.
- Long-term clozapine use can lead to hematological side effects, necessitating careful monitoring.
Observation:
- A patient with paranoid schizophrenia developed significant leukopenia after over a decade of stable clozapine treatment.
- Initial attempts to manage leukopenia by discontinuing clozapine and switching to olanzapine were unsuccessful, leading to symptom exacerbation.
Findings:
- Lithium carbonate administration stimulated white blood cell production, allowing for the successful reintroduction of clozapine.
- The patient was maintained on a combination of clozapine and lithium, with normalized white blood cell counts and absolute neutrophil counts (ANC).
Implications:
- Lithium may serve as an effective adjunct therapy to manage clozapine-induced leukopenia, potentially allowing for continued treatment with this vital medication.
- This case highlights a potential strategy to mitigate a serious adverse effect of clozapine, improving patient outcomes and adherence.
More Related Videos
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...